Jun 16, 2009 By:Stephanie Skernivitz Contemporary Pediatrics
Children and teens who are using stimulant medications may have slightly greater risk of sudden unexplained death, according to new research.
 |
Apr 7, 2009 By:Stephanie Skernivitz Contemporary Pediatrics
Teva is now selling generic versions of Shire Plc's ADHD drug Adderall XR in the US, years before its patent expires.
 |
Oct 24, 2008 By:John Merriman
Young people with ADHD may be at increased risk of becoming addicted to tobacco, according to a report in the Journal of Pediatrics.
 |
Oct 21, 2008 By:John Merriman
Tobacco smoke and lead exposure may be linked to a particularly high risk of ADHD, according to findings presented at the 2008 Annual Meeting of the Society for Developmental and Behavioral Pediatrics.
 |
Aug 8, 2008 By:John Merriman
The American Academy of Pediatrics (AAP) has stated it does not support the routine use of electrocardiogram (ECG) screening before initiating treatment with stimulants for children and adolescents with attention deficit hyperactivity disorder (ADHD).
 |
Jul 25, 2008 By:John Merriman
ADHD diagnoses for children ages 6 to 17 have on average increased 3% per year from 1997 through 2006, according to the Centers for Disease Control and Prevention (CDC).
 |
May 1, 2008 By:Julia A. McMillan, MD Contemporary Pediatrics
The challenges of child ADHD and how important medications and support from family, school, and outside activities are to the child.
 |
May 1, 2008 By:Michael S. Jellinek, MD Contemporary Pediatrics
Medication remains the mainstay of pediatric ADHD treatment. But these efforts can be complemented by non-medication approaches, targeted at the major areas of functioning in a child's life.
 |
Dec 1, 2007 By:H. Lynn Starr, MD Contemporary Pediatrics
ADHD is an equal-opportunity condition, affecting children from all walks of life. But what role, if any, does ethnicity have on the response to diagnosis and treatment?
 |
|